Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study.
about
Sex differences in stroke: the contribution of coagulationAntiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.Thrombolytic therapy at systemic lupus onset with secondary antiphospholipid syndrome. A rare stroke experience.The impact of gender on clinical manifestations of primary antiphospholipid syndrome.Outcomes of patients with antiphospholipid syndrome after pulmonary endarterectomy.Antiphospholipid syndrome and the brain in pediatric and adult patientsRelation of antiphospholipid antibodies to postmortem brain infarcts in older people.Epidemiology and etiology of young stroke.Treatment of risk factors to prevent stroke.Natural antibodies, autoantibodies and complement activation in tissue injury.Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study.The promise and potential pitfalls of serum biomarkers for ischemic stroke and transient ischemic attackGuidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Screening for coagulation disorders in patients with ischemic stroke.A review of hereditary and acquired coagulation disorders in the aetiology of ischaemic stroke.The management of stroke in antiphospholipid syndrome.Incidence, pathophysiology, and clinical manifestations of antiphospholipid syndrome.Does B lymphocyte-mediated autoimmunity contribute to post-stroke dementia?Presence of Anticardiolipin Antibodies in Patients with Dementia: A Systematic Review and Meta-Analysis.Anticardiolipin antibodies are associated with cognitive dysfunction in stroke-free individuals.Patent foramen ovale and atrial septal aneurysm can cause ischemic stroke in patients with antiphospholipid syndrome.A role for autoantibodies in atherogenesis.
P2860
Q27022768-A6A86126-24E8-4F9B-BC77-EFCB7AA8D0F4Q30355477-6E2B8B0B-E48B-437D-980D-1D524802737FQ30886508-7DBC5A9F-76C9-437C-8CC6-02B2B4299A57Q33368554-81A5D87E-463D-49AC-8EEB-646C8ABBCA57Q33412248-B7C2FB9E-C6D1-4E26-B0C5-C4E84F22BA8AQ34307502-3A8A69DA-D4EB-4BF5-A8DD-51CB3BFB8B60Q34943841-63E64E54-7838-4062-A0A9-7683777D4D67Q35116961-C578C5C9-565F-4A03-91E3-ECD9850C272FQ35648075-0F8D754E-98D5-467D-843F-1F870D250994Q36572982-7A14F18D-55B0-4404-B36D-AFA8C1562B5FQ36802556-71007C15-A79A-4FD1-8134-B7AB152365C5Q37212726-4DB37038-0DE8-4C2A-9D00-7F510107C6D1Q37251490-DA52C120-137E-41D0-A0BE-B697F853A7BCQ37775992-04668D00-7213-4665-9380-11477B0B75B3Q37790448-E9AC7286-8475-4870-AC09-5A7C7986911CQ37959884-7A198488-2BEB-4482-B16C-9EEB564227B7Q38591312-CDAA13C4-0BC2-40BE-A951-8839492E6BC2Q38929223-3FEF83F8-CD9C-451A-9324-03AE96EB4180Q41203115-2C976DD5-8D82-4C32-A4C4-CD4EF7D5643AQ44024893-4DEC8342-9EC4-4B85-BA2B-88D1ABD73D6FQ45344078-35608F77-ED7C-44B9-A460-28F354C27029Q47623831-276F0990-43F0-4F03-8420-02C2C5AE8088
P2860
Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Anticardiolipin antibodies and ...... am cohort and offspring study.
@en
type
label
Anticardiolipin antibodies and ...... am cohort and offspring study.
@en
prefLabel
Anticardiolipin antibodies and ...... am cohort and offspring study.
@en
P2093
P1433
P1476
Anticardiolipin antibodies and ...... am cohort and offspring study.
@en
P2093
Carl Franzblau
Carlos S Kase
Peter W F Wilson
Philip A Wolf
Ralph B D'Agostino
Vallabh Janardhan
P304
P356
10.1161/01.STR.0000117575.48205.2D
P407
P577
2004-02-05T00:00:00Z